Convertibles Calendar: Jazz in the market

On The Horizon

JAZZ PHARMACEUTICALS PLC:

• $500 million exchangeable senior notes due 2024

• $75 million greenshoe

• Price talk 1.5% yield, up 50%

• Rule 144A offering

• Morgan Stanley & Co. LLC (bookrunner)

• Contingently convertible

• Provisionally callable after three years

• Proceeds will be used to repay some or all of the company’s $500 million of outstanding borrowings under a revolving credit facility. Any remaining funds will be used for general corporate purposes, including possible business development activities.

• Dublin, Ireland-based biopharmaceutical company

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.